Compound ID | 1957
Synonym(s): VNRX-7145
Class: Beta-lactamase inhibitor (boron-based)
| Details of activity: | Binds to beta-lactamases with a focus on serine enzymes (class A, C, D). Fixed combination with ceftibuten |
| Combined with other compounds: | Yes |
| Description: | Synthetic compound. In clinical development in fixed combination with ceftibuten. Prodrug VNRX-5236 etzadroxil for oral application |
| Institute where first reported: | VenatoRx Pharmaceuticals |
| Year first mentioned: | 2017 |
| Highest developmental phase: | Phase 1 (as of 2022) |
| Development status: | Active (as of 2022) |
| Chemical structure(s): | |||||||||||
|
|